Loading...
Date of Award
Spring 2024
Degree Name
Master of Medical Science (Physician Assistant)
Department
Physician Assistant; College of Health Sciences
First Advisor
Dr. Kevin Basile
Abstract
There is no standardized method for management of polypharmacy in any population group. To prevent adverse outcomes and medication related problems and to maintain patient safety, current procedures for prescription management in vulnerable groups such as the geriatric and intellectual or developmental disability (IDD) populations must be understood. There is some criteria suggestions for the elderly population, but no such criteria established specifically for the IDD population who often experience polypharmacy, particularly with psychotropic medications. Current principles for polypharmacy management in the IDD population will be reviewed and assessed for efficacy, outcomes, and ease of use. The goal of this article is to review various polypharmacy protocols and explore how providers can implement such methods in the IDD population.
Recommended Citation
Schaner, Erin, "Polypharmacy management in the intellectually or developmentally disabled population" (2024). Capstone Showcase. 41.
https://scholarworks.arcadia.edu/showcase/2024/pa/41
Polypharmacy management in the intellectually or developmentally disabled population
There is no standardized method for management of polypharmacy in any population group. To prevent adverse outcomes and medication related problems and to maintain patient safety, current procedures for prescription management in vulnerable groups such as the geriatric and intellectual or developmental disability (IDD) populations must be understood. There is some criteria suggestions for the elderly population, but no such criteria established specifically for the IDD population who often experience polypharmacy, particularly with psychotropic medications. Current principles for polypharmacy management in the IDD population will be reviewed and assessed for efficacy, outcomes, and ease of use. The goal of this article is to review various polypharmacy protocols and explore how providers can implement such methods in the IDD population.